Literature DB >> 2020372

Reduced levels of calcitonin gene-related peptide-like immunoreactivity in human brain vessels after subarachnoid haemorrhage.

L Edvinsson1, R Ekman, I Jansen, J McCulloch, A Mortensen, R Uddman.   

Abstract

Human cerebral vessels were found to contain calcitonin gene-related peptide (CGRP)-like immunoreactivity (-LI) which in the reversed phase HPLC co-eluted with authentic human alpha-CGRP. The level was significantly lower in arteries removed from patients who had died from a subarachnoid haemorrhage (SAH) as compared to patients who died of a coronary infarction. On a molar basis human alpha-CGRP was more potent than human beta-CGRP to dilate human brain vessels and to dilate vasoconstriction elicited by whole blood. It is suggested that the trigemino-cerebrovascular system storing CGRP-LI may be involved in the pathophysiology of SAH in man.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020372     DOI: 10.1016/0304-3940(91)90672-g

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Cerebral vasospasm: a consideration of the various cellular mechanisms involved in the pathophysiology.

Authors:  Jacob Hansen-Schwartz
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 2.  Calcitonin gene-related peptide. Potential role in vascular disorders.

Authors:  A Shulkes
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 3.  The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine.

Authors:  Fred Cohen; Hsiangkuo Yuan; E M G DePoy; Stephen D Silberstein
Journal:  Neurotherapeutics       Date:  2022-04-14       Impact factor: 6.088

Review 4.  Gene therapy for cerebral vascular disease: update 2003.

Authors:  Kazunori Toyoda; Yi Chu; Donald D Heistad
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

5.  Alterations in perivascular dilatory neuropeptides (CGRP, SP, VIP) in the external jugular vein and in the cerebrospinal fluid following subarachnoid haemorrhage in man.

Authors:  R Juul; H Hara; S E Gisvold; A O Brubakk; T A Fredriksen; G Waldemar; J F Schmidt; R Ekman; L Edvinsson
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  Effect of subarachnoid haemorrhage on trigeminovascular calcitonin-gene-related peptide and substance P of the rat dura mater versus cerebral vasculature.

Authors:  A G Arand; M Zuccarello; B A Skidmore; R J Berger; J T Keller
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Role of calcitonin gene-related peptide in cerebral vasospasm, and as a therapeutic approach to subarachnoid hemorrhage.

Authors:  Stelios Kokkoris; Peter Andrews; David J Webb
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-15       Impact factor: 5.555

8.  Relationship of calcitonin gene-related peptide with disease progression and prognosis of patients with severe traumatic brain injury.

Authors:  Li-Xiong Chen; Wei-Feng Zhang; Ming Wang; Pi-Feng Jia
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

9.  Effect of recombinant adeno-associated virus expressing calcitonin gene-related peptide on chick embryo umbilical artery vasospasm model.

Authors:  Yongjie Yuan; Si Yang; Chao Li; Kan Xu; Jinlu Yu
Journal:  Exp Ther Med       Date:  2017-11-01       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.